---
document_datetime: 2025-12-29 13:42:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/starlix.html
document_name: starlix.html
version: success
processing_time: 0.1016558
conversion_datetime: 2025-12-31 05:06:38.032963
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Starlix

[RSS](/en/individual-human-medicine.xml/65888)

##### Withdrawn

This medicine's authorisation has been withdrawn

nateglinide Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 29 April 2022, the European Commission withdrew the marketing authorisation for Starlix (nateglinide) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Novartis Europharm Limited, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Starlix was granted marketing authorisation in the EU on 03 April 2001 for treatment of type 2 diabetes. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2006.

The European Public Assessment Report (EPAR) for Starlix is updated to indicate that the marketing authorisation is no longer valid.

Starlix : EPAR - Summary for the public

English (EN) (613.12 KB - PDF)

**First published:** 07/11/2007

**Last updated:** 28/06/2022

[View](/en/documents/overview/starlix-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-210)

български (BG) (787.46 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/bg/documents/overview/starlix-epar-summary-public_bg.pdf)

español (ES) (616.32 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/es/documents/overview/starlix-epar-summary-public_es.pdf)

čeština (CS) (767.27 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/cs/documents/overview/starlix-epar-summary-public_cs.pdf)

dansk (DA) (615.69 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/da/documents/overview/starlix-epar-summary-public_da.pdf)

Deutsch (DE) (617.69 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/de/documents/overview/starlix-epar-summary-public_de.pdf)

eesti keel (ET) (615.69 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/et/documents/overview/starlix-epar-summary-public_et.pdf)

ελληνικά (EL) (793.93 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/el/documents/overview/starlix-epar-summary-public_el.pdf)

français (FR) (617.14 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/fr/documents/overview/starlix-epar-summary-public_fr.pdf)

italiano (IT) (616.16 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/it/documents/overview/starlix-epar-summary-public_it.pdf)

latviešu valoda (LV) (771.88 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/lv/documents/overview/starlix-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (732.44 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/lt/documents/overview/starlix-epar-summary-public_lt.pdf)

magyar (HU) (758.59 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/hu/documents/overview/starlix-epar-summary-public_hu.pdf)

Malti (MT) (769.36 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/mt/documents/overview/starlix-epar-summary-public_mt.pdf)

Nederlands (NL) (616.82 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/nl/documents/overview/starlix-epar-summary-public_nl.pdf)

polski (PL) (774.47 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/pl/documents/overview/starlix-epar-summary-public_pl.pdf)

português (PT) (617.04 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/pt/documents/overview/starlix-epar-summary-public_pt.pdf)

română (RO) (726.33 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/ro/documents/overview/starlix-epar-summary-public_ro.pdf)

slovenčina (SK) (763.18 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sk/documents/overview/starlix-epar-summary-public_sk.pdf)

slovenščina (SL) (744.45 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sl/documents/overview/starlix-epar-summary-public_sl.pdf)

Suomi (FI) (616.11 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/fi/documents/overview/starlix-epar-summary-public_fi.pdf)

svenska (SV) (615.7 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sv/documents/overview/starlix-epar-summary-public_sv.pdf)

## Product information

Starlix : EPAR - Product Information

English (EN) (1.11 MB - PDF)

**First published:** 07/12/2007

**Last updated:** 28/06/2022

[View](/en/documents/product-information/starlix-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-159)

български (BG) (2.05 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/bg/documents/product-information/starlix-epar-product-information_bg.pdf)

español (ES) (1.17 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/es/documents/product-information/starlix-epar-product-information_es.pdf)

čeština (CS) (1.76 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/cs/documents/product-information/starlix-epar-product-information_cs.pdf)

dansk (DA) (1.1 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/da/documents/product-information/starlix-epar-product-information_da.pdf)

Deutsch (DE) (1.12 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/de/documents/product-information/starlix-epar-product-information_de.pdf)

eesti keel (ET) (1.08 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/et/documents/product-information/starlix-epar-product-information_et.pdf)

ελληνικά (EL) (2.1 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/el/documents/product-information/starlix-epar-product-information_el.pdf)

français (FR) (1.22 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/fr/documents/product-information/starlix-epar-product-information_fr.pdf)

hrvatski (HR) (1.22 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/hr/documents/product-information/starlix-epar-product-information_hr.pdf)

íslenska (IS) (1.09 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/is/documents/product-information/starlix-epar-product-information_is.pdf)

italiano (IT) (1.17 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/it/documents/product-information/starlix-epar-product-information_it.pdf)

latviešu valoda (LV) (1.81 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/lv/documents/product-information/starlix-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.24 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/lt/documents/product-information/starlix-epar-product-information_lt.pdf)

magyar (HU) (1.77 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/hu/documents/product-information/starlix-epar-product-information_hu.pdf)

Malti (MT) (1.8 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/mt/documents/product-information/starlix-epar-product-information_mt.pdf)

Nederlands (NL) (1.11 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/nl/documents/product-information/starlix-epar-product-information_nl.pdf)

norsk (NO) (1.15 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/no/documents/product-information/starlix-epar-product-information_no.pdf)

polski (PL) (1.76 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/pl/documents/product-information/starlix-epar-product-information_pl.pdf)

português (PT) (1.13 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/pt/documents/product-information/starlix-epar-product-information_pt.pdf)

română (RO) (1.23 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/ro/documents/product-information/starlix-epar-product-information_ro.pdf)

slovenčina (SK) (1.77 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/sk/documents/product-information/starlix-epar-product-information_sk.pdf)

slovenščina (SL) (1.72 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/sl/documents/product-information/starlix-epar-product-information_sl.pdf)

Suomi (FI) (1.09 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/fi/documents/product-information/starlix-epar-product-information_fi.pdf)

svenska (SV) (1.23 MB - PDF)

**First published:**

07/12/2007

**Last updated:**

28/06/2022

[View](/sv/documents/product-information/starlix-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0040 08/11/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Starlix : EPAR - All Authorised presentations

English (EN) (583.78 KB - PDF)

**First published:** 07/11/2007

**Last updated:** 28/06/2022

[View](/en/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_en.pdf)

[Other languages (20)](#file-language-dropdown-336)

български (BG) (674.04 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/bg/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_bg.pdf)

español (ES) (584.08 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/es/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_es.pdf)

čeština (CS) (629.08 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/cs/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (578.44 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/da/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (583.5 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/de/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_de.pdf)

ελληνικά (EL) (741.64 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/el/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_el.pdf)

français (FR) (584.72 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/fr/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (585.43 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/it/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (669.3 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/lv/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (654.3 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/lt/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (666.1 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/hu/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (664.54 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/mt/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (584.28 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/nl/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_nl.pdf)

polski (PL) (630.62 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/pl/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_pl.pdf)

português (PT) (584.46 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/pt/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_pt.pdf)

română (RO) (648.17 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/ro/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (629.5 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sk/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (618.03 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sl/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (584.58 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/fi/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (582.36 KB - PDF)

**First published:**

07/11/2007

**Last updated:**

28/06/2022

[View](/sv/documents/all-authorised-presentations/starlix-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Starlix Active substance nateglinide International non-proprietary name (INN) or common name nateglinide Therapeutic area (MeSH) Diabetes Mellitus, Type 2 Anatomical therapeutic chemical (ATC) code A10BX03

### Pharmacotherapeutic group

Drugs used in diabetes

### Therapeutic indication

Nateglinide is indicated for combination therapy with metformin in type-2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.

## Authorisation details

EMA product number EMEA/H/C/000335 Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Marketing authorisation issued 03/04/2001 Revision 15

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Starlix : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (855.08 KB - PDF)

**First published:** 07/12/2007

**Last updated:** 28/06/2022

[View](/en/documents/procedural-steps-after/starlix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Starlix : EPAR - Steps taken after authorisation when a cutoff date has been used

English (EN) (660.38 KB - PDF)

**First published:** 09/08/2006

**Last updated:** 28/06/2022

[View](/en/documents/steps-after-cutoff/starlix-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf)

## Initial marketing authorisation documents

Starlix : EPAR - Procedural steps taken before authorisation

English (EN) (665.79 KB - PDF)

**First published:** 09/08/2006

**Last updated:** 28/06/2022

[View](/en/documents/procedural-steps/starlix-epar-procedural-steps-taken-authorisation_en.pdf)

Starlix : EPAR - Scientific Discussion

English (EN) (995.19 KB - PDF)

**First published:** 01/02/2004

**Last updated:** 28/06/2022

[View](/en/documents/scientific-discussion/starlix-epar-scientific-discussion_en.pdf)

**This page was last updated on** 28/06/2022

## Share this page

[Back to top](#main-content)